NORTHERN CLINICS OF ISTANBUL, vol.7, no.4, pp.321-328, 2020 (ESCI)
OBJECTIVE: In this study, we evaluated the influences of BRAF(V600E) mutation on clinicopathological features in incidentally found papillary thyroid microcarcinomas (PTMCs).